This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Nov 14;381(20):1962-1963.

doi: 10.1056/NEJMe1913048.

On the "Take" as a Biomarker

Lindsey R Baden¹, Inger K Damon¹

Affiliations

PMID: 31722158
DOI: 10.1056/NEJMe1913048

Editorial

On the "Take" as a Biomarker

Lindsey R Baden et al. N Engl J Med. 2019.

. 2019 Nov 14;381(20):1962-1963.

doi: 10.1056/NEJMe1913048.

Authors

Lindsey R Baden¹, Inger K Damon¹

Affiliation

¹ From the Centers for Disease Control and Prevention, Atlanta (I.K.D.).

PMID: 31722158
DOI: 10.1056/NEJMe1913048

No abstract available

PubMed Disclaimer

Comment on

Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, Hornung J, Weidenthaler H, Heery CR, Meyer TPH, Silbernagl G, Maclennan J, Chaplin P. Pittman PR, et al. N Engl J Med. 2019 Nov 14;381(20):1897-1908. doi: 10.1056/NEJMoa1817307. N Engl J Med. 2019. PMID: 31722150 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information